# Eli Lilly Acquires Merida Biosciences as Markets Slip

**Published:** 2026-09-07T08:12:40.240Z  
**Topic:** S P 500  
**Sentiment:** neutral  
**Publisher:** TrendWatcher — https://www.trendwatcher.in/article/777a6d22-1424-4e47-be5d-aaaf7541b349

Eli Lilly buys Merida Biosciences for $2.875 billion as S&P 500 stocks fall. Markets react to rising oil prices and hawkish Fed signals from Kevin Warsh.

Eli Lilly will acquire Merida Biosciences for up to $2.875 billion in cash, marking the drugmaker's latest effort to deploy capital from its obesity-drug windfall into new therapeutic areas [3]. The deal coincides with a broader market retreat as rising geopolitical tensions and hawkish Federal Reserve rhetoric push the 10-year Treasury yield to 4.75% [3].

| At a glance | |
|---|---|
| Merida Biosciences Deal | $2.875 Billion |
| 10-Year Treasury Yield | 4.75% |
| WTI Crude Oil | >$85 per barrel |
| GE Vernova Stock Move | -2% |

## Market reaction to macro pressures
Stocks traded lower to start the week as energy prices surged following an exchange of strikes between the U.S. and Iran over the weekend [3]. WTI crude climbed back above $85 a barrel, while international benchmark Brent crude rose above $90 [3]. These energy gains, paired with a hawkish speech from Federal Reserve Chairman Kevin Warsh at Jackson Hole, pressured broader equity indices [3]. Communication services led the market decline, while technology was the only S&P 500 sector to trade in positive territory during afternoon hours [3].

## Lilly’s acquisition strategy
The acquisition of Merida Biosciences targets a new class of biologics designed to degrade pathogenic autoantibodies, a departure from traditional immunosuppressive treatments [3]. CEO David Ricks stated that the company has completed more deals in 2026 than in all of 2025, utilizing cash flow generated by its obesity drug portfolio [3]. While some employers have recently dropped coverage for GLP-1 medications due to cost concerns, Ricks characterized the net impact on demand as "flat," arguing that treating obesity remains a more cost-effective long-term strategy for employers than managing the resulting health complications [3].

## Musk’s comments impact industrial shares
GE Vernova shares fell 2% on Monday following social media remarks from Elon Musk regarding SpaceX’s internal development of natural gas turbine blades [3]. Musk claimed that in-house casting could accelerate the production of power-generating equipment by up to 18 months [3]. Howmet Aerospace, which manufactures turbine blades, also saw its shares decline following the post [3]. Analysts at Jefferies noted that it could take at least four years for SpaceX to industrialize such a facility and navigate customer negotiations, suggesting that GE Vernova’s pricing power may remain intact in the near term [3].

## What to watch
*   **Economic Data:** Tuesday’s release of the JOLTS report, which will provide the latest data on job openings and the quits rate for July [3].
*   **Manufacturing Metrics:** Upcoming S&P Global and Institute for Supply Management (ISM) Manufacturing PMI readings [3].
*   **Earnings:** Medtronic is scheduled to report earnings before the opening bell on Tuesday [3].

The market remains focused on whether the current bottleneck in power-generating equipment will persist, as analysts monitor potential political pushbacks that could delay data center projects ahead of the midterm elections [3]. Meanwhile, Lilly’s aggressive M&A pace signals a continued effort to diversify its pipeline beyond its current obesity-focused revenue base [3].

## Sources
1. Futurism — [Don Lemon Says Elon Musk Is the Most Delicate Snowflake He's Ever...](https://futurism.com/don-lemon-elon-musk-delicate-snowflake)
2. Stfuelon — [STFUElon - The Martian Diaries: August 31, 2026 | STFUElon](https://stfuelon.com/)
3. CNBC — [Lilly taps obesity windfall for more M&A. Plus, Elon Musk remarks pull GE Vernova lower](https://www.cnbc.com/2026/08/31/lilly-taps-obesity-windfall-for-more-ma-plus-elon-musk-remarks-pull-ge-vernova-lower.html)
4. Benzinga — [‘Former Trillionaire’ Elon Musk Says Life Can’t Always Be... - Benzinga](https://www.benzinga.com/markets/market-summary/26/09/61609179/former-trillionaire-elon-musk-says-life-cant-always-be-about-the-problems-every-day-we-gotta-do-things-that-make-us-want-to-live)

---
Cite as: TrendWatcher, "Eli Lilly Acquires Merida Biosciences as Markets Slip", https://www.trendwatcher.in/article/777a6d22-1424-4e47-be5d-aaaf7541b349